Summary:
Clinical Trial for Ulcerative Colitis to Evaluate the Safety and Efficacy of the study medication in Subjects with Mild, Moderate or Severely Active Ulcerative Colitis. Duration of the study is 52 weeks with optional extension for eligible subjects
Criteria:- be ages 18-85
- Diagnosed with Ulcerative Colitis by colonoscopy or sigmoidoscopy and biopsy
- Received prior treatment (corticosteroids, anti-inflammatories, advanced drug therapies)
Qualified Participants May Receive:
- Study medication for duration of the clinical trial at no charge
- Medical care by Board Certified Gastroenterologist for the duration of the trial at no charge
- Study related procedures (colonoscopy or sigmoidoscopy) at no charge
- Compensation for participation and expenses up to $3,600 and more based on completion of study visits